A detailed history of Kbc Group Nv transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Kbc Group Nv holds 4,159 shares of DVAX stock, worth $53,692. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,159
Previous 4,159 -0.0%
Holding current value
$53,692
Previous $47,000 2.13%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

SELL
$13.09 - $14.98 $70,764 - $80,981
-5,406 Reduced 56.52%
4,159 $58,000
Q3 2023

Feb 15, 2024

SELL
$12.64 - $14.99 $68,331 - $81,035
-5,406 Reduced 56.52%
4,159 $61,000
Q2 2023

Jul 28, 2023

BUY
$9.85 - $13.17 $94,215 - $125,971
9,565 New
9,565 $124,000
Q4 2022

Feb 14, 2024

BUY
$10.27 - $13.29 $55,519 - $71,845
5,406 Added 129.98%
9,565 $102,000
Q3 2022

Feb 15, 2024

BUY
$9.93 - $17.44 $53,681 - $94,280
5,406 Added 129.98%
9,565 $100,000
Q3 2022

Nov 08, 2022

BUY
$9.93 - $17.44 $94,980 - $166,813
9,565 New
9,565 $100,000
Q2 2019

Jul 30, 2019

SELL
$3.65 - $7.89 $16,425 - $35,505
-4,500 Closed
0 $0
Q1 2019

Dec 03, 2019

BUY
$7.08 - $12.09 $31,860 - $54,405
4,500 New
4,500 $33,000
Q1 2019

May 10, 2019

SELL
$7.08 - $12.09 $31,860 - $54,405
-4,500 Closed
0 $0
Q4 2018

Dec 03, 2019

BUY
$8.14 - $13.28 $36,630 - $59,760
4,500 New
4,500 $41,000
Q4 2018

Jan 31, 2019

SELL
$8.14 - $13.28 $36,630 - $59,760
-4,500 Closed
0 $0
Q3 2018

Dec 03, 2019

BUY
$11.85 - $16.0 $53,325 - $72,000
4,500 New
4,500 $56,000
Q3 2018

Nov 14, 2018

SELL
$11.85 - $16.0 $53,325 - $72,000
-4,500 Closed
0 $0
Q2 2018

Dec 03, 2019

BUY
$15.15 - $20.75 $68,175 - $93,375
4,500 New
4,500 $69,000
Q2 2018

Aug 03, 2018

SELL
$15.15 - $20.75 $68,175 - $93,375
-4,500 Closed
0 $0
Q1 2018

Dec 03, 2019

BUY
$14.65 - $19.9 $65,925 - $89,550
4,500 New
4,500 $89,000
Q1 2018

May 09, 2018

SELL
$14.65 - $19.9 $54,205 - $73,630
-3,700 Closed
0 $0
Q4 2017

Dec 03, 2019

BUY
$17.3 - $24.08 $64,010 - $89,096
3,700
3,700 $69,000

Others Institutions Holding DVAX

About DYNAVAX TECHNOLOGIES CORP


  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.63B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Kbc Group Nv Portfolio

Follow Kbc Group Nv and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.